Latest News

Insilico will lead the initial phase, advancing ISM8969 through preclinical studies and into a phase 1 clinical trial for Parkinson’s disease.

The deal centers on ozureprubart, an anti-immunoglobulin E (IgE) antibody that could transform how patients manage life-threatening food allergies.

The new machine, now operational at the JOOTRH Victoria Annex, performs two crucial procedures: Therapeutic Plasma Exchange (TPE) and Red Blood Cell Exchange (RBC-X).

The medical city will occupy 221 feddan of land and incorporate 18 distinct specialized institutes, creating a comprehensive healthcare ecosystem.

The initiative creates a dual benefit by encouraging healthier lifestyles while simultaneously generating resources for critical healthcare needs.

The transaction marks the end of Pfizer’s involvement with ViiV Healthcare, as the American pharmaceutical giant sells its entire 11.7% stake in the company.

Orthopaedic surgeons from both Metropolitan Hospital and Marengo Asia Hospitals worked together to perform the procedures.

Built on Microsoft 365 Copilot, Power BI, and Microsoft Azure, the platform enables pharmacists to replace traditional pen-and-paper stock management systems with sophisticated digital tools.

Patients now complete their treatment in six months rather than the previous nine to twelve months, marking a significant advancement in the country’s fight against TB.

EU GMP certification confirms that Bioventure Healthcare meets the European Union’s demanding requirements for pharmaceutical manufacturing.